BacThera is a 50/50 joint venture between Lonza AG and Chr. Hansen to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. It operates from its headquarters in Basel (CH) and has production facilities in Denmark and Switzerland. Bacthera brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of live bacteria strains for therapeutic use.

Map

Show on map

Website

www.bacthera.com

Contact

+ 41 79 829 3831